SVS Guidelines Bundle

Abdominal Aortic Aneurysm

SVS GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, Enjoy!

Issue link:

Contents of this Issue


Page 11 of 23

Treatment 12 EVAR ➤ The SVS recommends preservation of flow to at least one internal iliac artery. (1-A) ➤ The SVS recommends using Food and Drug Administration (FDA)- approved branch endograft devices in anatomically suitable patients to maintain perfusion to at least one internal iliac artery. (1-A) ➤ The SVS recommends staging bilateral internal iliac artery occlusion by ≥1–2 weeks if required for EVAR. (1-A) ➤ The SVS suggests renal artery or superior mesenteric artery (SMA) angioplasty and stenting for selected patients with symptomatic disease before EVAR or OSR. (2-C) ➤ The SVS suggests prophylactic treatment of an asymptomatic, high-grade stenosis of the SMA in the presence of a meandering mesenteric artery based off of a large inferior mesenteric artery (IMA), which will be sacrificed during the course of treatment. (2-C) ➤ The SVS suggests preservation of accessory renal arteries at the time of EVAR or OSR if the artery is ≥3 mm in diameter or supplies more than one-third of the renal parenchyma. (2-C) Perioperative Outcomes of Elective EVAR ➤ The SVS suggests that elective EVAR be performed at centers with a volume of ≥10 EVAR cases each year and a documented perioperative mortality and conversion rate to OSR of ≤2%. (2-C) Role of Elective EVAR in the High-Risk and Unfit Patient ➤ The SVS suggests informing high-risk patients of their VQI perioperative mortality risk score to make an informed decision to proceed with aneurysm repair. (2-C) OSR ➤ The SVS recommends a retroperitoneal approach for patients requiring OSR of an inflammatory aneurysm, a horseshoe kidney, or an aortic aneurysm in the presence of a hostile abdomen. (1-C) ➤ The SVS suggests a retroperitoneal exposure or a transperitoneal approach with a transverse abdominal incision for patients with significant pulmonary disease requiring OSR. (2-C) ➤ The SVS recommends a thrombin inhibitor, such as bivalirudin or argatroban, as an alternative to heparin for patients with a history of heparin-induced thrombocytopenia. (1-B)

Articles in this issue

Archives of this issue

view archives of SVS Guidelines Bundle - Abdominal Aortic Aneurysm